MERCK KGAA - DE0006599905 (Stock)
/IBT-BA-HP/WEB-INF/snippets/root/general/name.jsp
1040
0
1040
111,75 EUR
|
-1,4116% |
25.07.2025 15:04
|
400,00 |
111,75 |
111,85 |
200,00 |
/IBT-BA-HP/WEB-INF/snippets/root/general/v2/infobar.jsp
0
0
0
/IBT-BA-HP/WEB-INF/snippets/root/general/toolbar.jsp
0
1
1
/IBT-BA-HP/WEB-INF/snippets/root/stock/navigation.jsp
1
1
2
|
Merck KGaA
Frankfurter Strasse 250
64293, Darmstadt, DE
|
| Phone |
+49-6151-72-0 |
| Fax |
+49-6151-72-5577 |
| Email |
|
| Internet |
http://www.merckgroup.com
|
| IR Contact/PR Contact |
Christian Raabe/- |
| Symbol |
MRCK |
| End of financial year |
31.12.2025 |
| Issued capital |
14.649.580.700,00 EUR |
/IBT-BA-HP/WEB-INF/snippets/root/company/contact.jsp
1071
0
1071
| Freefloat |
74,11% |
| First Eagle Investment Management LLC |
4,99% |
| The Vanguard Group, Inc. |
3,65% |
| Mondrian Investment Partners Ltd. |
3,10% |
| Amundi Asset Management SASU (Investment Management) |
3,05% |
| MFS International Singapore Pte Ltd. |
2,50% |
| BlackRock Fund Advisors |
2,30% |
| Norges Bank Investment Management |
2,02% |
| BlackRock Advisors (UK) Ltd. |
1,78% |
| Geode Capital Management LLC |
1,25% |
| Union Investment Privatfonds GmbH |
1,25% |
/IBT-BA-HP/WEB-INF/snippets/root/company/shareholders.jsp
35
0
35
| Helene von Roeder |
Member of Executive Committee |
| Belén Garijo López |
Member of Executive Committee |
| Dr. Matthias Heinzel |
Member of Executive Committee |
| Dr. Kai Beckmann |
Member of Executive Committee |
| Peter Guenter |
Member of Executive Committee |
| Michael Kleinemeier |
Chairman of Supervisory Board |
| Anne Lange |
Member of Supervisory Board |
| Barbara Lambert |
Member of Supervisory Board |
| Birgit Biermann |
Member of Supervisory Board |
| Jürgen Glaser |
Member of Supervisory Board |
| Peter Emanuel Merck |
Member of Supervisory Board |
| Renate Koehler |
Member of Supervisory Board |
| Sascha Held |
Member of Supervisory Board |
| Dr. Simon Thelen |
Member of Supervisory Board |
| Dr. Helga Rübsamen-Schaeff |
Member of Supervisory Board |
| Dr. Gabriele Eismann |
Member of Supervisory Board |
| Dr. Dietmar Oeter |
Member of Supervisory Board |
| Dr. Daniel Thelen |
Member of Supervisory Board |
| Dr. Alexander Putz |
Member of Supervisory Board |
| Dr. Christian Raabe |
Member of Supervisory Board |
/IBT-BA-HP/WEB-INF/snippets/root/company/board.jsp
43
0
43
|
Activity Description
|
|
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.
|
/IBT-BA-HP/WEB-INF/snippets/root/company/corporateactions.jsp
48
0
48
